Insulet Balance Sheet
NASDAQ: PODDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Insulet financial position
At the end of fiscal 2025, Insulet reported total assets of $3.19 billion, up 3.3% from a year earlier against total liabilities of $1.68 billion. Shareholders' equity stood at $1.52 billion, or 47.5% of assets. The company held $716.1 million in cash and equivalents against $949.2 million of debt, a net debt position of $233.1 million.
The current ratio (current assets divided by current liabilities) was 2.81, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.63.
Summary generated from market data by MetaCap's automated system. Methodology
Insulet balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 716.10M | 953.40M | 704.20M | 689.80M | 806.40M | 907.20M | 213.70M | 113.90M | 272.58M | 137.17M |
| Short-Term Investments | — | — | — | — | 0 | 40.40M | 162.40M | 175.00M | 167.48M | 161.40M |
| Receivables | 516.90M | — | — | 140.90M | 135.20M | 95.30M | 69.30M | 63.30M | 53.37M | 28.80M |
| Inventory | 452.60M | 430.40M | 402.60M | 346.80M | 303.20M | 154.30M | 101.00M | 71.40M | 33.79M | 35.51M |
| Total Current Assets | 1.91B | 1.89B | 1.58B | 1.31B | 1.33B | 1.25B | 591.00M | 461.30M | 537.17M | 369.96M |
| Property, Plant & Equipment | 819.50M | 723.10M | 664.90M | 599.90M | 536.50M | 478.70M | 399.40M | 258.40M | 107.86M | 44.75M |
| Goodwill | 51.60M | 51.50M | 51.70M | 51.70M | 39.80M | 39.80M | 39.80M | 39.60M | 39.80M | 39.68M |
| Intangible Assets | 117.10M | 98.50M | 98.70M | 75.50M | 36.60M | 28.70M | 13.20M | 10.38M | 4.35M | 2.04M |
| Long-Term Investments | — | — | — | — | — | 0 | 58.40M | 140.80M | 125.55M | 0 |
| Total Assets | 3.19B | 3.09B | 2.59B | 2.25B | 2.05B | 1.87B | 1.14B | 928.70M | 816.74M | 456.65M |
| Accounts Payable | 75.00M | 19.80M | 19.20M | 30.80M | 37.70M | 54.10M | 54.50M | 25.50M | 24.41M | 13.16M |
| Short-Term Debt | 18.40M | 83.80M | 49.40M | 27.50M | 25.10M | 15.60M | 0 | — | 0 | — |
| Total Current Liabilities | 680.10M | 528.40M | 451.20M | 364.70M | 228.80M | 207.80M | 157.70M | 115.70M | 86.03M | 55.70M |
| Long-Term Debt | 930.80M | 1.30B | 1.37B | 1.37B | 1.25B | 1.04B | 887.90M | 592.00M | 566.17M | 332.77M |
| Total Liabilities | 1.68B | 1.88B | 1.86B | 1.77B | 1.49B | 1.27B | 1.07B | 716.60M | 658.23M | 393.50M |
| Shareholders' Equity | 1.52B | 1.21B | 732.70M | 476.40M | 556.30M | 603.60M | 75.90M | 212.10M | 158.50M | 63.10M |
| Retained Earnings | 287.40M | 40.30M | -378.00M | -584.30M | -649.50M | -666.30M | -672.00M | -683.60M | -707.25M | -680.42M |
| Total Debt | 949.20M | 1.38B | 1.42B | 1.40B | 1.27B | 1.06B | 887.90M | 592.00M | 566.17M | 332.77M |
| Net Cash (Debt) | -233.10M | -426.50M | -711.60M | -712.00M | -467.50M | -111.70M | -511.80M | -303.10M | -126.12M | -34.20M |
| Shares Outstanding | 70.39M | 70.20M | 69.91M | 69.51M | 69.18M | 66.02M | 62.69M | 59.19M | 58.32M | 57.46M |
This table shows 10 annual periods of Insulet's balance sheet, from FY 2025 back to FY 2016, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PODD's reporting calendar. What is a balance sheet?